Trial intelligence / Profile preview

High Dose vs Standard Dose Influenza Vaccine in LTC

NCT01654224Phase 4Completed

Sponsor
University of Pittsburgh
Start
Nov 2011
Primary completion
Jun 2014
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of influenza virus vaccine, split virion in influenza, sponsored by University of Pittsburgh. Started Nov 2011; status: completed.

02

Drugs

influenza virus vaccine, split virion
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01654224.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01654224.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call